Here are three stocks with buy ranks and strong growth characteristics for investors to consider today, February 2:
Dollar General Corporation DG: This discount retailer carries a Zacks Rank #1, and has witnessed the Zacks Consensus Estimate for its current year earnings increasing 5.5% over the last 60 days.
Dollar General Corporation Price and Consensus
Dollar General Corporation price-consensus-chart | Dollar General Corporation Quote
Dollar General has a PEG ratio of 2.61 comparedwith 3.00 for the industry. The company possesses a Growth Scoreof B.
Dollar General Corporation PEG Ratio (TTM)
Dollar General Corporation peg-ratio-ttm | Dollar General Corporation Quote
Ciena Corporation CIEN: This network technology company carries a Zacks Rank #1, and has witnessed the Zacks Consensus Estimate for its current year earnings increasing 21.6% over the last 60 days.
Ciena Corporation Price and Consensus
Ciena Corporation price-consensus-chart | Ciena Corporation Quote
Ciena has a PEG ratio of 1.14 compared with 5.41 for the industry. The company possesses a Growth Score of A.
Ciena Corporation PEG Ratio (TTM)
Ciena Corporation peg-ratio-ttm | Ciena Corporation Quote
Casey’s General Stores, Inc. CASY: This convenience retail company carries a Zacks Rank #1, and has witnessed the Zacks Consensus Estimate for its current year earnings increasing 6.2% over the last 60 days.
Casey’s General Stores, Inc. Price and Consensus
Casey’s General Stores, Inc. price-consensus-chart | Casey’s General Stores, Inc. Quote
Casey’s General Stores has a PEG ratio of 2.14 compared with 2.54 for the industry. The company possesses a Growth Score of A.
Casey’s General Stores, Inc. PEG Ratio (TTM)
Casey’s General Stores, Inc. peg-ratio-ttm | Casey’s General Stores, Inc. Quote
See also <!DOCTYPE html><html><head> <title>Navigating the September Stock Market Blues with Medical Stocks</title></head><body><h2>Understanding the September Stock Market Trends</h2><p>Historically, September has proven to be a tumultuous month for stock investors. Dubbed the September Effect, this phenomenon is characterized by increased market volatility and lower overall stock performance, often influenced by economic policy decisions and higher trading volumes post-summer.</p><h2>Why Medical Stocks Might Be Your Best Bet</h2><p>During seasons of heightened market uncertainty, many investors turn to defensive sectors such as healthcare for stability and protection against market downturns. As the demand for essential services remains consistent, medical stocks are often viewed as a safe haven amid the September storm.</p><h2>DaVita: A Strong Contender</h2><p>DaVita, a leading provider of dialysis services, has been turning heads with its impressive stock performance, soaring over 40% year-to-date. With a Zacks Rank #1 (Strong Buy) and attractive valuation metrics, DaVita seems well-positioned to weather the storm of September. Analysts predict steady revenue growth for the company in the upcoming fiscal years, adding to its appeal for investors seeking stability.</p><h2>HCA Healthcare: Riding the Wave</h2><p>Another top player in the medical stocks arena is HCA Healthcare, the largest operator of non-governmental acute care hospitals in the US. With a Zacks Rank #1 (Strong Buy) and a robust earnings outlook, HCA Healthcare has seen its stock price climb over 40% this year. The company's focus on value and consistent revenue expansion make it a compelling choice for investors looking for solid returns.</p><h2>Eli Lilly: Innovating for Success</h2><p>Eli Lilly has been making waves in the pharmaceutical industry with its innovative drug pipeline catering to the needs of Type 2 diabetics. With a Zacks Rank #2 (Buy) and a strong market presence in the diabetes and obesity treatment space, Eli Lilly is well-positioned for growth in the coming years. The company's aggressive growth projections and positive sentiment around its products make it a promising option for investors seeking exposure to the healthcare sector.</p><h2>Looking Ahead</h2><p>As investors brace themselves for the uncertainties of September, the allure of medical stocks shines bright. With companies like DaVita, HCA Healthcare, and Eli Lilly displaying resilience and growth potential, these stocks may serve as anchors in an otherwise turbulent market. Keeping a keen eye on market trends and leveraging the stability of healthcare stocks could be the winning strategy for navigating the September Effect.</p></body></html><!DOCTYPE html><html><head> <title>Exploring Top Medical Stocks Amid Market Volatility</title></head><body> Unveiling Top Medical Stocks Amid Market Uncertainty
See the full list of top ranked stocks here.
Learn more about the Growth score and how it is calculated here.
#1 Semiconductor Stock to Buy (Not NVDA)
The incredible demand for data is fueling the market’s next digital gold rush. As data centers continue to be built and constantly upgraded, the companies that provide the hardware for these behemoths will become the NVIDIAs of tomorrow.
One under-the-radar chipmaker is uniquely positioned to take advantage of the next growth stage of this market. It specializes in semiconductor products that titans like NVIDIA don’t build. It’s just beginning to enter the spotlight, which is exactly where you want to be.
See This Stock Now for Free >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Dollar General Corporation (DG) : Free Stock Analysis Report
Ciena Corporation (CIEN) : Free Stock Analysis Report
Casey’s General Stores, Inc. (CASY) : Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.
